HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Six hundred fifty-six consecutive explorations for primary hyperparathyroidism.

AbstractOBJECTIVE:
To review the outcomes of 656 consecutive parathyroid explorations performed by a single surgeon and to compare the results of conventional and minimally invasive parathyroidectomy (MIP) techniques.
SUMMARY BACKGROUND DATA:
Traditional surgery for primary hyperparathyroidism (HPTH) involves bilateral cervical exploration, which is usually accomplished under general endotracheal anesthesia. The MIP technique involves preoperative localization with sestamibi scans, surgeon-administered cervical block anesthesia, directed exploration through a small incision, intraoperative rapid parathyroid hormone assay, and discharge within 2 to 3 hours of surgery.
METHODS:
Six hundred fifty-six consecutive patients with primary HPTH underwent exploration between January 1990 and March 2001.
RESULTS:
MIP was used with ever-increasing frequency beginning in March 1998. Four hundred one procedures (61%) were performed using the standard technique and 255 patients (39%) were selected for MIP. The success rate for the entire series was 98%, with no significant differences comparing traditional and MIP techniques. The overall complication rate of 2.3% reflects 3.0% and 1.2% rates in the standard and MIP groups, respectively. MIP was associated with approximately a 50% reduction in operating time, a sevenfold reduction in length of hospital stay, and a mean cost savings of $2,693 per procedure, which represents nearly a 50% reduction in total hospital charges.
CONCLUSIONS:
A dramatic and sustained shift has occurred in the surgical treatment of primary HPTH: MIP has replaced traditional exploration for most patients.
AuthorsRobert Udelsman
JournalAnnals of surgery (Ann Surg) Vol. 235 Issue 5 Pg. 665-70; discussion 670-2 (May 2002) ISSN: 0003-4932 [Print] United States
PMID11981212 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Radiopharmaceuticals
  • Technetium Tc 99m Sestamibi
Topics
  • Cost Savings
  • Databases, Factual
  • Female
  • Hospital Charges
  • Humans
  • Hyperparathyroidism (diagnostic imaging, epidemiology, surgery)
  • Length of Stay (statistics & numerical data)
  • Male
  • Middle Aged
  • Minimally Invasive Surgical Procedures (economics, statistics & numerical data)
  • Outcome and Process Assessment, Health Care
  • Parathyroidectomy (economics, methods)
  • Preoperative Care
  • Prospective Studies
  • Radionuclide Imaging
  • Radiopharmaceuticals
  • Technetium Tc 99m Sestamibi

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: